Related Experiment Video

Updated: Jan 25, 2026

Radiosensitivity of Cancer Stem Cells in Lung Cancer Cell Lines
09:45

Radiosensitivity of Cancer Stem Cells in Lung Cancer Cell Lines

Published on: August 21, 2019

7.5K

SBF2-AS1: An oncogenic lncRNA in small-cell lung cancer

Youwei Zhang1, Yang Li2, Liang Han1

  • 1Department of Medical Oncology, Xuzhou Central Hospital, Xuzhou Medical University, Xuzhou, China.

Journal of Cellular Biochemistry
|May 4, 2019
PubMed

Insights

The long noncoding RNA SBF2-AS1 is upregulated in small-cell lung cancer (SCLC), promoting tumor growth and metastasis. High SBF2-AS1 expression indicates a poor prognosis for SCLC patients.

Area of Science:

  • Molecular Biology
  • Oncology
  • Genetics

Background:

  • Long noncoding RNAs (lncRNAs) play critical roles in various cancers.
  • SBF2 antisense RNA 1 (SBF2-AS1) is implicated as an oncogenic lncRNA in non-small-cell lung cancer (NSCLC).
  • The specific role of SBF2-AS1 in small-cell lung cancer (SCLC) remains largely uncharacterized.

Purpose of the Study:

  • To investigate the clinical significance of SBF2-AS1 in SCLC.
  • To elucidate the biological function of SBF2-AS1 in SCLC progression.

Main Methods:

  • Quantitative real-time PCR (qRT-PCR) to assess SBF2-AS1 expression levels in SCLC tissues and cell lines.
  • Correlation analysis to associate SBF2-AS1 expression with clinical parameters (stage, tumor size, metastasis).
  • Kaplan-Meier survival analysis to evaluate the prognostic value of SBF2-AS1.
  • In vitro experiments (e.g., cell proliferation, migration, invasion assays) to determine the functional impact of SBF2-AS1 inhibition.

Main Results:

  • SBF2-AS1 expression is significantly upregulated in SCLC tissues and cell lines compared to NSCLC tissues/lines and normal lung tissues.
  • High SBF2-AS1 expression correlates with advanced clinical stage, larger tumor size, lymph node metastasis, and distant metastasis in SCLC patients.
  • Elevated SBF2-AS1 levels are associated with shorter overall survival and serve as an independent poor prognostic factor in SCLC.
  • Inhibition of SBF2-AS1 in vitro demonstrably suppresses SCLC cell proliferation, migration, and invasion.

Conclusions:

  • SBF2-AS1 functions as a novel oncogenic lncRNA in small-cell lung cancer.
  • SBF2-AS1 holds potential as a diagnostic marker and therapeutic target for SCLC.
Keywords:
SBF2-AS1biomarkerlong noncoding RNAslung cancer

More Related Videos

Detection of Targetable Alterations in Non-small Cell Lung Cancer using Next-generation Sequencing05:17

Detection of Targetable Alterations in Non-small Cell Lung Cancer using Next-generation Sequencing

Published on: October 10, 2025

370
Methods for Evaluating the Role of c-Fos and Dusp1 in Oncogene Dependence10:09

Methods for Evaluating the Role of c-Fos and Dusp1 in Oncogene Dependence

Published on: January 7, 2019

8.7K

Related Concept Videos

lncRNA - Long Non-coding RNAs02:39

lncRNA - Long Non-coding RNAs

In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA...
9.8K
lncRNA - Long Non-coding RNAs02:39

lncRNA - Long Non-coding RNAs

3.6K
Cancer-Critical Genes I: Proto-oncogenes01:33

Cancer-Critical Genes I: Proto-oncogenes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
11.2K
Lung Capacity01:47

Lung Capacity

The air in the lungs is measured in volumes and capacities. Lung volume measures reflect the amount of air taken in, released, or left over after a lung function, like a single inhalation. Lung capacity measures are sums of two or more lung volume measures.
56.2K
Cancer Cell Migration through Invadopodia01:35

Cancer Cell Migration through Invadopodia

Invadosome is a broad category of cell surface structures with proteolytic activity that  degrades the extracellular matrix (ECM). Invadosomes are present in normal cell types, including macrophages, endothelial cells, and neurons, as well as tumor cells. Although the macrophage podosomes and tumor cell invadopodia are classified as invadosomes, they have different structures, molecular pathways, and functions. Podosomes are short structures that last for a few minutes. However,...
3.2K
Adaptive Mechanisms in Cancer Cells02:53

Adaptive Mechanisms in Cancer Cells

Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
7.0K